Anshu Shrestha, PhD
Dr. Shrestha has extensive experience in designing and implementing observational studies, including designing questionnaires and data extraction forms to evaluate the relation between treatment types or treatment adherence and health outcomes. At PHE, she has been involved in overseeing observational studies that require either secondary analysis of large claims data or primary data collection through survey or chart review on various chronic diseases including hemophilia, diabetes, and cancer. Prior to PHE, Dr. Shrestha worked in the epidemiology department of the UCLA School of Public Health, where she investigated early life factors and childhood cancer using 20 years of registry data. Before that, Dr. Shrestha worked in various capacities on a wide range of research studies, including as a research associate/project manager on projects evaluating national level substance-related policy programs in the Department of Social Science & Health Policy of the Wake Forest University School of Medicine.
PhD, Epidemiology, University of California, Los Angeles
MPH, Epidemiology, University of California, Los Angeles
BS, Biology and Mathematics, Salem College
- Seabury SA, et al. Patient outcomes and cost effects of Medicaid formulary restrictions on antidepressants. Forum Health Econ Policy. 2014.
- Shafrin J, et al. Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers. Patient Prefer Adherence. 2017.
- Shrestha A, et al. Real-world resource use and costs of haemophilia A-related bleeding. Haemophilia.
- Siris ES, et al. Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage. Clin Interv Aging. 2015.